Interethnic differences in drug oxidation. Implications for the utilization of antidepressants and neuroleptics

Clin Neuropharmacol. 1992:15 Suppl 1 Pt A:88A-89A. doi: 10.1097/00002826-199201001-00047.

Authors

M L Dahl¹, I Johansson, Q Y Yue, J Säwe, L Bertilsson, M Ingelman-Sundberg, F Sjöqvist

Affiliation

¹ Department of Clinical Pharmacology, Karolinska Institute, Huddinge Hospital, Sweden.

PMID: 1354075
DOI: 10.1097/00002826-199201001-00047

No abstract available

MeSH terms

Antidepressive Agents / pharmacokinetics*
Antidepressive Agents / therapeutic use
Antipsychotic Agents / pharmacokinetics*
Antipsychotic Agents / therapeutic use
Ethnicity*
Humans
Oxidation-Reduction

Substances

Antidepressive Agents
Antipsychotic Agents